The Slovakian market for hormones in dosage, excluding contraceptives and antibiotics, experienced a consistent decline over the past decade, culminating in a market size of $35.924 million USD in 2023. Notably, the market's year-on-year variations were marked by double-digit decreases, especially in 2022 and 2023. The compound annual growth rate (CAGR) for the last five years is a negative 10.37%, emphasizing a prolonged downtrend.

Future trends to watch for include:

Potential stabilization as the rate of decline appears to moderate.
The impact of technological advancements in hormone-related treatments.
Shifts in regulatory policies and health care coverage influencing market demand.